Current periprocedural management of ablation for atrial fibrillation in Europe: Results of the European Heart Rhythm Association survey

Europace

Volumn 16, Issue 3, 2014, Pages 378-381

  Chen, Jian ^a   Todd, Derick M ^b   Hocini, Mélèze ^c   Larsen, Torben Bjerregaard ^d   Bongiorni, Maria Grazia ^e   Blomström Lundqvist, Carina ^f  

^a UNIVERSITY OF BERGEN   (Norway)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d AALBORG UNIVERSITY   (Denmark)

^e UNIVERSITY HOSPITAL OF PISA   (Italy)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

Ablation; Anticoagulation; Atrial fibrillation; EHRA survey; EP wire; Periprocedural management

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN;

ABLATION THERAPY; ALTERNATIVE ENERGY; ANTICOAGULANT THERAPY; ARTICLE; ATRIOESOPHAGEAL FISTULA; BLOOD CLOTTING TIME; BLOOD VESSEL FISTULA; CARDIAC IMAGING; CARDIOVASCULAR PROCEDURE; CARDIOVASCULAR RISK; CHADS2 SCORE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY MONITORING; ESOPHAGUS FISTULA; GENERAL ANESTHESIA; HEALTH CARE SURVEY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HOLTER MONITORING; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRACARDIAC ECHOCARDIOGRAPHY; LOADING DRUG DOSE; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT PREFERENCE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOFREQUENCY; RECURRENT DISEASE; SEDATION; TEMPERATURE MEASUREMENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSSEPTAL PUNCTURE; TREATMENT INDICATION;

ABLATION; ANTICOAGULATION; ATRIAL FIBRILLATION; EHRA SURVEY; EP WIRE; PERIPROCEDURAL MANAGEMENT;

ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; EUROPE; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; PREVALENCE; TREATMENT OUTCOME;

EID: 84895727631     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu043     Document Type: Article

References (11)

1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
2. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
3. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
4. Frykman V, Beerman B, Rydén L, Rosenqvist M. Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J 2001;22:1954-9.
5. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013;15:625-51.
6. Hohnloser SH, Camm AJ. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: ameta-analysis of the literature. Europace 2013;15:1407-11.
7. Lip GY, Proclemer A, Dagres N, Bongiorni MG, Lewalter T, Blomström-Lundqvist C. Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation. Europace 2012;14:741-4.
8. Lewalter T, Dobreanu D, Proclemer A, Marinskis G, Pison L, Blomström-Lundqvist C. Atrial fibrillation ablation techniques. Europace 2012;14:1515-7.
9. Deshmukh A, Patel NJ, Pant S, Shah N, Chothani A, Mehta K, et al. In-hospital complications associatedwith catheterablationof atrial fibrillationin the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation 2013;128:2104-12.
10. Dagres N, Hindricks G, Kottkamp H, Sommer P, Gaspar T, Bode K et al. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J Cardiovasc Electrophysiol 2009;20:1014-9.
11. Aldhoon B, Wichterle D, Peichl P, Čihák R, Kautzner J. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace 2013;15:24-32.